Novarad to Showcase VisAR at AANS 2026, Bringing Augmented Reality into Neurosurgical Workflows
At AANS 2026, Novarad will demonstrate how its VisAR augmented reality platform brings three-dimensional, spatially aligned imaging into neurosurgical workflows — giving surgeons greater clarity in the operating room.
Provo, UT (PRUnderground) May 1, 2026
Novarad, a leader in medical imaging and visualization solutions, will exhibit its augmented reality platform, VisAR, at the AANS Annual Scientific Meeting, taking place May 1–4 in San Antonio, Texas.
Attendees can visit Booth 825 to experience live demonstrations of VisAR and see how augmented reality is being applied within neurosurgical workflows.
VisAR enables surgeons to visualize patient imaging data in a three-dimensional, spatially aligned format, supporting enhanced anatomical understanding and procedural planning. Designed for real-world clinical environments, the platform integrates with existing imaging systems to deliver intuitive, intraoperative visualization without disrupting established workflows.
“Augmented reality has the potential to bring greater clarity into the operating room,” said Dr. Wendell Gibby, CEO. “At AANS, we’re focused on demonstrating how VisAR can be applied in practical settings to support precision and confidence during neurosurgical procedures.”
Visitors to the Novarad booth will have the opportunity to explore real-world use cases, interact with the technology firsthand, and speak with the team about implementation and integration within their clinical environments.
Event Details
- Event: AANS Annual Scientific Meeting
- Dates: May 1–4, 2026
- Location: San Antonio, Texas
- Booth: 825
- Exhibit Hours:
- Friday, May 1: 6:00 PM – 7:00 PM
- Saturday, May 2: 8:00 AM – 4:00 PM
- Sunday, May 3: 8:00 AM – 2:30 PM
About Novarad
Novarad has been a pioneer in medical imaging software for over three decades, delivering enterprise imaging solutions, advanced visualization tools, and augmented reality technology to healthcare providers worldwide. The company’s platforms are designed to improve clinical workflows, enhance diagnostic capabilities, and support better patient outcomes.
Also published on
Distributed via PR Underground